clinigen group plc
(CLIN:London Stock Exchange)
Ian James Nicholson B.Sc., MBA
Non-Executive Director, Chairman of Remuneration Committee, Member of Nomination Committee and Member of Audit & Risk Committee, Clinigen Group Plc
|Age||Total Calculated Compensation||This person is connected to 0 board members in 4 different organizations across 8 different industries.|
Mr. Ian James Nicholson, B.Sc., MBA, has been the Chief Business Officer at NeRRe Therapeutics Ltd since March 2014. Mr. Nicholson has been the Chief Executive Officer of F2G Ltd. since March 2013. Mr. Nicholson has been an Operating Partner at Advent Venture Partners since December 17, 2012. He is employed as a part of the life sciences team. He served as the Chief Executive Officer of Chroma Therapeutics Ltd. from 2004 to July 2012. Mr. Nicholson joined Chroma in September ...
Pitcairn HousePhone: 44 12 8349 4340
Burton-on-Trent, Staffordshire DE14 2WW
Board Members Memberships*
Former Chief Executive Officer and Director
Non-Executive Chairman, Member of Remuneration Committee and Member of Nomination Committee
Non-Executive Director, Chairman of Corporate Responsibility (CR) Committee, Member of Remuneration Committee, Member of Nomination Committee and Member of Audit Committee
Non-Executive Director, Chairman of Remuneration Committee, Member of Nomination Committee and Member of Audit & Risk Committee
Chief Executive Officer and Executive Director
University College London
Other Affiliations*There is no Company Affiliations data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|